Eusol Biotech Co.,Ltd. (TPEX:6652)
Taiwan · Delayed Price · Currency is TWD 1.960
0.00 (0.00%)
Apr 9, 2026, 2:59 PM CST
Eusol Biotech Revenue
In the year 2025, Eusol Biotech had annual revenue of 2.08M TWD. Eusol Biotech had revenue of 1.71M in the half year ending December 31, 2025.
Revenue
2.08M
Revenue Growth
n/a
P/S Ratio
129.28
Revenue / Employee
n/a
Employees
39
Market Cap
268.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.08M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Level Biotechnology | 736.59M |
| TCI GENE | 273.61M |
| BioLASCO Taiwan | 262.66M |
| RBC Bioscience | 201.85M |
| NatureWise Biotech & Medicals | 180.29M |
| Feng Chi Biotech | 177.36M |
| Visgeneer | 159.76M |
| Vectorite Biomedical | 67.90M |